|
Dec 7
|
Gilead Sciences: The Bull Case Is More Powerful Than You Think
|
|
Dec 7
|
Gilead's Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
|
|
Dec 6
|
Great week for Gilead Sciences, Inc. (NASDAQ:GILD) institutional investors after losing 6.8% over the previous year
|
|
Dec 2
|
Is Gilead Sciences, Inc.'s (NASDAQ:GILD) ROE Of 26% Impressive?
|
|
Dec 1
|
Gilead Employees Stitch Together To Create a Special Panel of the AIDS Quilt
|
|
Nov 30
|
Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
|
|
Nov 30
|
2 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
Nov 29
|
Gilead to lay off staff at cell therapy unit Kite
|
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
|
Nov 28
|
Gilead's Ambition: To Help End the HIV Epidemic
|
|
Nov 26
|
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
|
|
Nov 26
|
15 Best Drug Stocks To Invest In
|
|
Nov 24
|
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals, Dynavax and Ligand Pharmaceuticals
|
|
Nov 16
|
Arcellx (ACLX) Up 5% on Partnership Expansion With Gilead
|
|
Nov 15
|
Arcellx Stock Surges as Gilead Adds to Stake, Expands Collaboration
|
|
Nov 15
|
ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP
|
|
Nov 15
|
Kite and Arcellx Announce Expansion in Strategic Partnership
|
|
Nov 14
|
Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS
|
|
Nov 14
|
Jim Simons Stock Portfolio: 12 Biggest Healthcare Stocks
|
|
Nov 10
|
Gilead Sciences (NASDAQ:GILD) shareholders YoY returns are lagging the company's 19% three-year earnings growth
|